Public Profile

Ipca Laboratories

Ipca Laboratories Limited, headquartered in Mumbai, India, is a prominent player in the pharmaceutical industry, specialising in the manufacture and export of active pharmaceutical ingredients (APIs) and finished dosage forms. Founded in 1949, the company has achieved significant milestones, including a robust presence in over 100 countries and a diverse product portfolio that encompasses a wide range of therapeutic areas such as cardiovascular, anti-infective, and pain management. With a commitment to quality and innovation, Ipca Laboratories stands out for its extensive range of generic formulations and APIs, which are produced in state-of-the-art facilities adhering to international standards. The company has garnered a strong market position, recognised for its consistent growth and contributions to healthcare, making it a trusted name in the global pharmaceutical landscape.

DitchCarbon Score

How does Ipca Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

21

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Ipca Laboratories's score of 21 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.

15%

Let us know if this data was useful to you

Ipca Laboratories's reported carbon emissions

In 2024, Ipca Laboratories reported total carbon emissions of approximately 311,883,000 kg CO2e. This figure reflects their ongoing commitment to sustainability within the pharmaceutical industry. In the previous year, 2023, the company disclosed emissions of about 311,883,000 kg CO2e, with Scope 1 emissions at approximately 174,538,000 kg CO2e and Scope 2 emissions at around 137,345,000 kg CO2e. Ipca Laboratories has set an ambitious target to achieve a 20% reduction in carbon emissions by 2030, covering both Scope 1 and Scope 2 emissions. This commitment, initiated in 2022, underscores their proactive approach to mitigating climate impact. The company is currently on track to meet this near-term reduction goal. Overall, Ipca Laboratories is focused on enhancing its sustainability practices and reducing its carbon footprint, aligning with industry standards and climate commitments.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20222023
Scope 1
124,880,000
000,000,000
Scope 2
179,114,000
000,000,000
Scope 3
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Ipca Laboratories's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Ipca Laboratories is in IN, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Ipca Laboratories is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Alembic Pharmaceuticals

IN
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Lupin

IN
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Glaxosmithkline

GB
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Mankind Pharma

IN
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Torrent Pharmaceuticals

IN
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Intas

IN
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers